PIPA5103651
B3GALT5 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5103651-Each-of-1 | In Stock | ₹ 44,705.10 |
PIPA5103651 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,705.10
GST (18%): ₹ 8,046.918
Total Price: ₹ 52,752.018
Antigen
B3GALT5
Classification
Polyclonal
Conjugate
Unconjugated
Gene
B3GALT5
Gene Alias
1190002B21Rik; AU045265; B3GALT5; b3Gal-T5; b3Galt-V; B3GalTx; B3gt5; B3T5; Beta-1,3-galactosyltransferase 5; beta-1,3-GalTase 5; beta-3-galactosyltransferase 5; beta3GalT5; beta3Gal-T5; beta-3-Gx-T5; GLCT5; homolog of C. elegans Bt toxin resistance gene bre-5; SSEA-3 synthase; Stage-specific embryonic antigen 3 synthase; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
10317
Content And Storage
-20°C
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
Q9Y2C3
Gene Symbols
B3GALT5
Immunogen
A synthesized peptide derived from human B3GALT5(Accession Q9Y2C3), corresponding to amino acid residues M85-T135.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total B3GALT5
- B3GALT5 catalyzes the transfer of Gal to GlcNAc-based acceptors with a preference for the core3 O-linked glycan GlcNAc(beta1,3)GalNAc structure
- Can use glycolipid LC3Cer as an efficient acceptor
- (Uniprot)
Compare Similar Items
Show Difference
Antigen: B3GALT5
Classification: Polyclonal
Conjugate: Unconjugated
Gene: B3GALT5
Gene Alias: 1190002B21Rik; AU045265; B3GALT5; b3Gal-T5; b3Galt-V; B3GalTx; B3gt5; B3T5; Beta-1,3-galactosyltransferase 5; beta-1,3-GalTase 5; beta-3-galactosyltransferase 5; beta3GalT5; beta3Gal-T5; beta-3-Gx-T5; GLCT5; homolog of C. elegans Bt toxin resistance gene bre-5; SSEA-3 synthase; Stage-specific embryonic antigen 3 synthase; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 10317
Content And Storage: -20°C
Form: Liquid
Applications: Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: Q9Y2C3
Gene Symbols: B3GALT5
Immunogen: A synthesized peptide derived from human B3GALT5(Accession Q9Y2C3), corresponding to amino acid residues M85-T135.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human
Product Type: Antibody
Isotype: IgG
Antigen:
B3GALT5
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
B3GALT5
Gene Alias:
1190002B21Rik; AU045265; B3GALT5; b3Gal-T5; b3Galt-V; B3GalTx; B3gt5; B3T5; Beta-1,3-galactosyltransferase 5; beta-1,3-GalTase 5; beta-3-galactosyltransferase 5; beta3GalT5; beta3Gal-T5; beta-3-Gx-T5; GLCT5; homolog of C. elegans Bt toxin resistance gene bre-5; SSEA-3 synthase; Stage-specific embryonic antigen 3 synthase; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
10317
Content And Storage:
-20°C
Form:
Liquid
Applications:
Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
Q9Y2C3
Gene Symbols:
B3GALT5
Immunogen:
A synthesized peptide derived from human B3GALT5(Accession Q9Y2C3), corresponding to amino acid residues M85-T135.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Antigen: B3GALT6
Classification: Polyclonal
Conjugate: Unconjugated
Gene: B3GALT6
Gene Alias: b3galt6; BB129894; Beta-1,3-galactosyltransferase 6; beta-1,3-GalTase 6; beta3GalT6; beta3Gal-T6; EDSP2; GAG GalTII; galactosyltransferase II; Galactosylxylosylprotein 3-beta-galactosyltransferase; GalTII; SEMDJL1; UDP-Gal:betaGal beta 1,3-galactosyltransferase 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 117592, 126792
Content And Storage: -20°C
Form: Liquid
Applications: Immunocytochemistry, Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: Q91Z92, Q96L58
Gene Symbols: B3GALT6
Immunogen: A synthesized peptide derived from human B3GALT6(Accession Q96L58), corresponding to amino acid residues H239-K289.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse
Product Type: Antibody
Isotype: IgG
Antigen:
B3GALT6
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
B3GALT6
Gene Alias:
b3galt6; BB129894; Beta-1,3-galactosyltransferase 6; beta-1,3-GalTase 6; beta3GalT6; beta3Gal-T6; EDSP2; GAG GalTII; galactosyltransferase II; Galactosylxylosylprotein 3-beta-galactosyltransferase; GalTII; SEMDJL1; UDP-Gal:betaGal beta 1,3-galactosyltransferase 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
117592, 126792
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunocytochemistry, Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
Q91Z92, Q96L58
Gene Symbols:
B3GALT6
Immunogen:
A synthesized peptide derived from human B3GALT6(Accession Q96L58), corresponding to amino acid residues H239-K289.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse
Product Type:
Antibody
Isotype:
IgG
Antigen: B4GALT2
Classification: Polyclonal
Conjugate: Unconjugated
Gene: B4galt2
Gene Alias: 4-Gal; B4galt2; B4Gal-T2; B4Gal-T3; Beta-1,4-galactosyltransferase 2; beta-1,4-galactosyltransferase II; beta-1,4-GalTase 2; beta-4-GalT2; beta4Gal-T2; Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 2; Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase; Ggtb2; Lactose synthase A protein; N-acetyllactosamine synthase; Nal synthase; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 53418, 8704
Content And Storage: -20°C
Form: Liquid
Applications: Immunocytochemistry, Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: O60909, Q9Z2Y2
Gene Symbols: B4galt2
Immunogen: A synthesized peptide derived from human B4GALT2(Accession O60909), corresponding to amino acid residues F112-L162.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse
Product Type: Antibody
Isotype: IgG
Antigen:
B4GALT2
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
B4galt2
Gene Alias:
4-Gal; B4galt2; B4Gal-T2; B4Gal-T3; Beta-1,4-galactosyltransferase 2; beta-1,4-galactosyltransferase II; beta-1,4-GalTase 2; beta-4-GalT2; beta4Gal-T2; Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 2; Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase; Ggtb2; Lactose synthase A protein; N-acetyllactosamine synthase; Nal synthase; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 2; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
53418, 8704
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunocytochemistry, Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
O60909, Q9Z2Y2
Gene Symbols:
B4galt2
Immunogen:
A synthesized peptide derived from human B4GALT2(Accession O60909), corresponding to amino acid residues F112-L162.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse
Product Type:
Antibody
Isotype:
IgG
Antigen: B4GALT4
Classification: Polyclonal
Conjugate: Unconjugated
Gene: B4GALT4
Gene Alias: 9130402O08Rik; B4GALT4; b4Gal-T4; B4galt-IV; Beta-1,4-galactosyltransferase 4; beta-1,4-galactosyltransferase IV; beta-1,4-GalTase 4; beta4Gal-T4; beta4GalT-IV; beta-N-acetylglucosaminyl; Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 4; Lactotriaosylceramide beta-1,4-galactosyltransferase; N-acetyllactosamine synthase; Nal synthase; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4; UNQ552/PRO1109
Host Species: Rabbit
Purification Method: Affinity chromatography
Regulatory Status: RUO
Gene ID (Entrez): 303923, 56375, 8702
Content And Storage: -20°C
Form: Liquid
Applications: Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 mg/mL
Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.: O60513, Q66HH1, Q9JJ04
Gene Symbols: B4GALT4
Immunogen: A synthesized peptide derived from human B4GALT4(Accession O60513), corresponding to amino acid residues S81-R131.
Quantity: 100 μL
Primary or Secondary: Primary
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
B4GALT4
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene:
B4GALT4
Gene Alias:
9130402O08Rik; B4GALT4; b4Gal-T4; B4galt-IV; Beta-1,4-galactosyltransferase 4; beta-1,4-galactosyltransferase IV; beta-1,4-GalTase 4; beta4Gal-T4; beta4GalT-IV; beta-N-acetylglucosaminyl; Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase; beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase 4; Lactotriaosylceramide beta-1,4-galactosyltransferase; N-acetyllactosamine synthase; Nal synthase; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 4; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4; UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4; UNQ552/PRO1109
Host Species:
Rabbit
Purification Method:
Affinity chromatography
Regulatory Status:
RUO
Gene ID (Entrez):
303923, 56375, 8702
Content And Storage:
-20°C
Form:
Liquid
Applications:
Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 mg/mL
Formulation:
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.:
O60513, Q66HH1, Q9JJ04
Gene Symbols:
B4GALT4
Immunogen:
A synthesized peptide derived from human B4GALT4(Accession O60513), corresponding to amino acid residues S81-R131.
Quantity:
100 μL
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG